Thus, the frequency of poorly differentiated HCC was the highest in the ≥3 M group (18.2%), followed by the ≥2 M group (8.3%), and single-marker groups (3.8% for DLK1, and 0% for NCAM, EpCAM, and CK19). This evidence concerns the gene KRT19 and hepatocellular carcinoma.